Santos David A

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 0% 8.2% 15.1%
Success rate 85% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Santos David A's trades of Rigel Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-06 2025-02-05
S Sale
79,673 +17.5%
67.59
US$710,785 		79,673 +17.5% 67.59 US$710,785
2025-02-05 2025-02-05
PrS Proposed sale
2,413
275.35
US$3,681,008 		2,413 275.35 US$3,681,008
2025-02-06 2025-02-04
S Sale
24,386 -46.9%
320.25
US$535,721 		24,386 -46.9% 320.25 US$535,721
2025-02-04 2025-02-04
PrS Proposed sale
2,125
20.92
US$44,458 		2,125 20.92 US$44,458
2024-02-06 2024-02-05
S Sale
8,918 -2.5%
1.14
US$10,167 		8,918 -2.5% 1.14 US$10,167
2024-02-06 2024-02-02
S Sale
5,601 -1.5%
1.13
US$6,329 		5,601 -1.5% 1.13 US$6,329
2023-02-06 2023-02-02
S Sale
5,388 -3.6%
1.66
US$8,945 		5,388 -3.6% 1.66 US$8,945